IN8bio
Income Statement

Last updated:

Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. over the previous period. Total operating expenses were $30,337,000.

Profit Margin

IN8bio, Inc. (NASDAQ:INAB): Profit margin
2018 0 -2.08M
2019 0 -5.13M
2020 0 -8.55M
2021 0 -14.65M
2022 0 -27.41M
2023 0 -30.00M

INAB Income Statement (2018 – 2023)

2023 2022 2021 2020 2019 2018
Revenue
Revenue
000000
Cost of revenue
2.50M1.10M251K96K96K0
Gross profit
-2.50M-1.10M-251K-96K-96K0
Operating exp.
Research and development
16.82M14.06M7.34M5.37M2.35M581K
Selling and marketing
000000
Total operating expenses
30.33M28.52M14.65M8.55M5.06M2.00M
Operating income
-30.33M-28.52M-14.65M-8.55M-5.13M-2.00M
Other income (expenses), net
330K000-68K-63K
Income before tax
-30.00M-28.52M-14.65M-8.55M-5.13M-2.08M
Income tax expense
0-1.10M0-118.29K-68K-63K
Net income
-30.00M-27.41M-14.65M-8.55M-5.13M-2.08M
Earnings per share
Basic EPS
-1-1.31-0.78-0.44-0.27-0.34
Diluted EPS
-1-1.31-0.78-0.44-0.27-0.34
Data sourceData sourceData source